Get the Stockscreener App
1.05
0.00%
0.00
Iridex Corp stock is traded at $1.05, with a volume of 1,143.
It is up +0.00% in the last 24 hours and up +5.36% over the past month.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
See More
Previous Close:
$1.05
Open:
$1.0401
24h Volume:
1,143
Relative Volume:
0.01
Market Cap:
$18.35M
Revenue:
$52.68M
Net Income/Loss:
$-4.44M
P/E Ratio:
-3.9894
EPS:
-0.2632
Net Cash Flow:
$-2.26M
1W Performance:
+1.94%
1M Performance:
+5.36%
6M Performance:
+0.48%
1Y Performance:
-8.70%
1-Day Range:
$1.0401
$1.055
1-Week Range:
$1.025
$1.10
52-Week Range:
$0.8688
$1.6481
Iridex Corp Stock (IRIX) Company Profile
Name
Iridex Corp
Sector
Industry
Phone
(650) 940-4700
Address
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Compare IRIX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.055 | 18.27M | 52.68M | -4.44M | -2.26M | -0.2632 |
ABT
Abbott Laboratories
|
86.51 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
293.27 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.50 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.50 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
81.46 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-17 | Resumed | ROTH Capital | Buy |
| Dec-21-16 | Initiated | ROTH Capital | Buy |
| Jan-26-16 | Initiated | Singular Research | Buy |
| Jan-03-07 | Initiated | First Albany | Buy |
Iridex Corp Stock (IRIX) Latest News
Iridex to Report First Quarter 2026 Financial Results on May 19, 2026 - The Manila Times
Iridex sets May 19 investor call with Q1 results after close - Stock Titan
MSN Money - MSN
Iridex (NASDAQ: IRIX) schedules 2026 meeting on board, pay, auditor - Stock Titan
IRIDEX Corporation (IRIX) Stock: What Affects Its Direction | Q4 2025: Profit SurprisesShort Interest - Cổng thông tin điện tử Tỉnh Sơn La
The Zacks Analyst Blog Microsoft, AbbVie, BHP, CBL & Associates Properties and IRIDEX - Zacks Investment Research
IRIDEX Corporation (IRIX) Stock Outlook | Q4 2025: EPS Tops ViewsCatalyst Event - Newser
Aug Reactions: Is IRIDEX Corporation forming a double bottomGDP Growth & Weekly High Return Stock Forecasts - baoquankhu1.vn
Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology - The Manila Times
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Wondering what's happening in today's after-hours session? - ChartMill
Iridex partners with EyeProGPO for retina laser distribution - Investing.com
More than 1,800 eye care members gain pricing access to Iridex lasers - Stock Titan
IRIX Should I Buy - Intellectia AI
IRIX.O Technical Analysis & Stock Price Forecast - Intellectia AI
IRIX.O PE Ratio & Valuation, Is IRIX.O Overvalued - Intellectia AI
IRIDEX Corporation: Innovative Ophthalmic Laser Solutions for Glaucoma and Retinal Diseases - Minichart
IRIDEX (NASDAQ: IRIX) 10% holder gets interest paid in stock - Stock Titan
Iridex 10-K: Revenue $52.7M, EPS $(0.26) - TradingView — Track All Markets
IRIDEX (NASDAQ: IRIX) boosts revenue, cuts loss and issues convertible debt - Stock Titan
Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth - Yahoo Finance
Iridex Reports Reduced Q4 Loss Compared to Last Year Due to Increased Retina Sales - Bitget
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
IRIDEX Corporation (NASDAQ:IRIX) Q4 2025 Earnings Call Transcript - Insider Monkey
IRIDEX Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
IRIDEX Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: IRIDEX Q4 2025 sees revenue growth, narrows losses - Investing.com Canada
IRIDEX earnings beat by $0.01, revenue topped estimates - Investing.com
IRIDEX Corp (NASDAQ:IRIX) Reports Mixed Q4 Results with Revenue Growth and Narrowed Loss - ChartMill
Iridex: Q4 Earnings Snapshot - Barchart
Iridex (IRIX) swings to positive 2025 adjusted EBITDA with 8% revenue growth - Stock Titan
Iridex Reports Fourth Quarter and Full Year 2025 Financial Results - Yahoo Finance
IPO Launch: Will IRIDEX Corporation benefit from geopolitical trendsPrice Action & Reliable Breakout Forecasts - baoquankhu1.vn
Analyst Upgrade: Does IRIDEX Corporation meet Warren Buffetts criteria2026 Institutional & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
IRIDEX Corp expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Signal Recap: Is IRIDEX Corporation showing insider buyingEarnings Miss & Accurate Intraday Trading Signals - baoquankhu1.vn
IRIDEX (IRIX) Projected to Post Earnings on Thursday - Defense World
Iridex Corporation Signs New Office Lease at Hellyer Oaks Technology Park in San Jose - Minichart
Iridex signs lease for new San Jose headquarters with 90-month term - Investing.com
Iridex signs lease for new San Jose headquarters with 90-month term By Investing.com - Investing.com South Africa
IRIDEX (IRIX) signs long-term San Jose headquarters lease with rent escalators - Stock Titan
Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026 - The Manila Times
Eye laser firm Iridex schedules March 26 reveal of 2025 results - Stock Titan
Insider Buying: Romeo Dizon Acquires Additional Shares of IRIDEX Corp (IRIX) - GuruFocus
Iridex CFO Dizon buys $1398 in IRIX stock By Investing.com - za.investing.com
Iridex CFO Dizon buys $1398 in IRIX stock - Investing.com
Iridex Corp Stock (IRIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Iridex Corp Stock (IRIX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dizon Romeo R | Chief Financial Officer |
Feb 17 '26 |
Buy |
1.34 |
2,200 |
2,942 |
119,890 |
| Dizon Romeo R | Chief Financial Officer |
Feb 12 '26 |
Buy |
1.43 |
1,500 |
2,145 |
117,690 |
| Dizon Romeo R | Chief Financial Officer |
Feb 10 '26 |
Buy |
1.46 |
1,000 |
1,460 |
116,190 |
| Dizon Romeo R | Chief Financial Officer |
Feb 03 '26 |
Buy |
1.38 |
2,500 |
3,450 |
115,190 |
| Dizon Romeo R | Chief Financial Officer |
Jan 29 '26 |
Buy |
1.44 |
1,101 |
1,588 |
112,690 |
| Dizon Romeo R | Chief Financial Officer |
Jan 28 '26 |
Buy |
1.46 |
1,300 |
1,898 |
111,589 |
| Dizon Romeo R | Chief Financial Officer |
Jan 27 '26 |
Buy |
1.48 |
3,385 |
5,009 |
110,289 |
| Dizon Romeo R | Chief Financial Officer |
Jan 26 '26 |
Buy |
1.52 |
1,243 |
1,889 |
106,904 |
| Dizon Romeo R | Chief Financial Officer |
Jan 23 '26 |
Buy |
1.48 |
5,221 |
7,716 |
105,661 |
| Dizon Romeo R | Chief Financial Officer |
Jan 21 '26 |
Buy |
1.50 |
2,159 |
3,233 |
100,440 |
0.76%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):